Risk factors for the development of bronchopulmonary dysplasia: A case-control study

Archives of Medical Research

Volumn 35, Issue 6, 2004, Pages 549-553

  Hernández Ronquillo, Lizbeth ^a   Téllez Zenteno, José Francisco ^b   Weder Cisneros, Natali ^c   Salinas Ramírez, Vicente ^c   Zapata Pallagi, James Albert ^c   Da Silva, Orlando ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

Author keywords

Bronchopulmonary dysplasia; Chronic lung disease; Patent ductus arteriosus; Respiratory distress syndrome; Risk factors; Sepsis

Indexed keywords

ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; INTENSIVE CARE UNIT; LUNG DYSPLASIA; LUNG VENTILATION; MALE; MEXICO; NEWBORN CARE; PATENT; RISK FACTOR; SEPSIS; STEROID THERAPY;

EID: 22944484745     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2004.07.001     Document Type: Article

References (25)

1. Northway WH, Rosan R, Porter D. Pulmonary disease following respiratory therapy or hyaline-membrane disease: bronchopulmonary dysplasia. New Engl J Med 1967;276(7):357-364.
2. Bancalari E. Epidemiology and risk factor for the "new" bronchopulmonary dysplasia. Pediatr Neorev 2000;1:e1-e5.
3. Avery ME, Tooley WH, Keller JB, Hurd SS, Bryan MH, Cotton RB, Epstein MF, Fitzhardinge PM, Hansen CB, Hansen TN. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 1987;79:26-30.
4. th ed. St Louis Missouri: Mosby;2001.
5. Farstad T, Bratlid D. Incidence and prediction of bronchopulmonary dysplasia in a cohort of premature infants. Acta Paediatr 1994;83:19-24.
6. Cardona J, Benítez G, Romero S, Salinas V, Morales M. Morbilidad neonatal en pacientes de muy bajo peso sometidos a ventilación mecánica. Perinatol Reprod Hum 1994;8:147-152.
7. Northway WH, Moss RB, Carlisle KB, Parker BR, Popp RL, Pitlick PT, Eichler I, Lamm RL, Brown BW Jr. Late pulmonary sequelae of bronchopulmonary dysplasia. N Engl J Med 1990;323:1793-1799.
8. Fernández-Carrocera LA. Neurodesarrollo y displasia broncopulmonar. In: Temas de Pediatría. Asociación Mexicana de Pediatría, A.C. Neonatología. Jasso GL, editor. Mexico: Nueva Editorial Panamericana;1996. pp. 13-21.
9. Barrera-Reyes RH, Fernández-Carrocera LA, Ortigosa CE, Martínez CC, Rodríguez PL. Comparación del neurodesarrollo al año y dos años de vida en pacientes con displasia broncopulmonar con y sin hemorragia subependimaria intraventricular. Bol Med Hosp Infant Mex 1999;56:550-556.
10. Singer L, Yamashita T, Lilien L, Collin M, Baley J. A longitudinal study of developmental outcome of infants with bronchopulmonary dysplasia and very low birth weight. Pediatrics 1997;100:987-993.
11. Bancalari E, Claure N, Sosenko I. Bronchopulmonary dysplasia: change in pathogenesis, epidemiology and definition. Semin Neonatol 2003;8:63-72.
12. Bancalari E, Abdenour GE, Feller R, Gannon J. Bronchopulmonary dysplasia: clinical presentation. J Pediatr 1979;95:819-823.
13. Stoll BJ, Hansen MPH, Fanarrof AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons JA, Donovan EF, Stark AR, Tyson JE, Oh W, Bauer CR, Korones SB, Shankaran S, Laptook AR, Stevenson DK, Papile LA, Poole WK. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002;110:285-291.
14. th edition. Fanaroff A, Martin RJ, editors. Portland, OR: MosbyYear Book;2002. pp. 1138-1140.
15. Arad I, Baras M, Gofin R, Bar-Oz B, Peleg O. Does parity affect the neonatal outcome of very-low-birth-weight infants? Eur J Obstet Gynecol Reprod B 2001;94:283-289.
16. Moretti M, Sigai B. Maternal and perinatal outcome of expectant management of premature rupture of membranes in the midtrimester. Am J Obstet Gynecol 1998;159:390-396.
17. Yoon BH, Romero R, Jun JK, Park KH, Prak JD, Ghezzi F, Kim BI. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997;177:825-830.
18. Hitti J, Krohn MA, Patton DL, Tarczy-Hornoch P, Hillier SL, Cassen EM, Eschenbach DA. Amniotic fluid tumor necrosis factor-alpha and the risk of respiratory distress syndrome among preterm infants. Am J Obstet Gynecol 1997;177:50-56.
19. Frank L, Sosenko I. Development of lung antioxidant enzyme system in late gestation: possible implications or prematurely born infant. J Pediatr 1987;110:9-14.
20. Lemons JA, Bauer CR, Oh W, Korones SB, Papile LA, Stoll BJ, Verter J, Temprosa M, Wright LL, Ehrenkranz RA, Fanaroff AA, Stark A, Carlo W, Tyson JE, Donovan EF, Shankaran S, Stevenson DK. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995-December 1996. NICHD Neonatal Research Network. Pediatrics 2001;107:E1.
21. Gonzalez A, Sosenko IRS, Chandar J, Hummler H, Clure N, Bancalari E. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less. J Pediatr 1996;128:470-178.
22. Pierce MR, Bancalari E. The role of inflammation in the pathogenesis of bronchopulmonary dysplasia. Pediatr Pulmonol 1995;19:371-378.
23. Rojas M, González A, Bancalari E, Claure N, Poole C, Silva G. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 1995;126:605-610.
24. Korhonen P, Tammela O, Koivisto A-M, Laippala P, Ikonen S. Frequency and risk factor in bronchopulmonary dysplasia in a cohort of very low birth weight infants. Early Human Dev 1999;54:245-258.
25. Saugstad OD. Bronchopulmonary dysplasia-oxidative stress and antioxidants. Semin Neonatol 2003;8:39-19.